Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 9, 2020The Journal of Headache and PainOpen Access

Multidimensional assessment of the effects of erenumab in chronic migraine patients with previous unsuccessful preventive treatments: a comprehensive real-world experience

View Full Paper
Ask AI
Bookmark
Share

Authors

ARAntonio RussoUniversity of SalernoMSMarcello SilvestroUniversity of Campania "Luigi Vanvitelli"FCFabrizio Scotto di ClementeUniversity of Campania "Luigi Vanvitelli"

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Russo et al. (2020) studied this question.

synapsesocial.com/papers/6a19a3d405af093a17f65ccdhttps://doi.org/10.1186/s10194-020-01143-0
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1A subjective cognitive impairment scale for migraine attacks. The MIG-SCOG: Development and validation2011 · 44 citations
  2. 2Sociodemographic and comorbidity profiles of chronic migraine and episodic migraine sufferers2010 · 628 citations
  3. 3Real-life data on the efficacy and safety of erenumab in the Abruzzo region, central Italy2020 · 173 citations
  4. 4Erenumab in Chronic Migraine Patients Who Previously Failed Five First-Line Oral Prophylactics and OnabotulinumtoxinA: A Dual-Center Retrospective Observational Study2020 · 92 citations